Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

755 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immunogenicity of a low-dose diphtheria, tetanus and acellular pertussis combination vaccine with either inactivated or oral polio vaccine compared to standard-dose diphtheria, tetanus, acellular pertussis when used as a pre-school booster in UK children: A 5-year follow-up of a randomised controlled study.
John T, Voysey M, Yu LM, McCarthy N, Baudin M, Richard P, Fiquet A, Kitchin N, Pollard AJ. John T, et al. Among authors: pollard aj. Vaccine. 2015 Aug 26;33(36):4579-85. doi: 10.1016/j.vaccine.2015.06.105. Epub 2015 Jul 10. Vaccine. 2015. PMID: 26165918 Free article. Clinical Trial.
Immunogenicity and safety of a low-dose diphtheria, tetanus and acellular pertussis combination vaccine with either inactivated or oral polio vaccine as a pre-school booster in UK children.
Collins CL, Salt P, McCarthy N, Chantler T, Lane L, Hemme F, Diggle L, Buttery J, Kitchin NR, Moxon ER, Pollard AJ. Collins CL, et al. Among authors: pollard aj. Vaccine. 2004 Oct 22;22(31-32):4262-9. doi: 10.1016/j.vaccine.2004.04.027. Vaccine. 2004. PMID: 15474717 Clinical Trial.
Serogroup C meningococcal glycoconjugate vaccine in adolescents: persistence of bactericidal antibodies and kinetics of the immune response to a booster vaccine more than 3 years after immunization.
Snape MD, Kelly DF, Salt P, Green S, Snowden C, Diggle L, Borkowski A, Yu LM, Moxon ER, Pollard AJ. Snape MD, et al. Among authors: pollard aj. Clin Infect Dis. 2006 Dec 1;43(11):1387-94. doi: 10.1086/508776. Epub 2006 Oct 31. Clin Infect Dis. 2006. PMID: 17083009 Clinical Trial.
A randomized study comparing the safety and immunogenicity of a conjugate vaccine combination containing meningococcal group C and pneumococcal capsular polysaccharide--CRM197 with a meningococcal group C conjugate vaccine in healthy infants: challenge phase.
Riddell A, Buttery JP, McVernon J, Chantler T, Lane L, Bowen-Morris J, Diggle L, Morris R, Lockhart S, Pollard AJ, Cartwright K, Moxon ER. Riddell A, et al. Among authors: pollard aj. Vaccine. 2007 May 10;25(19):3906-12. doi: 10.1016/j.vaccine.2007.01.097. Epub 2007 Feb 7. Vaccine. 2007. PMID: 17368663 Clinical Trial.
755 results